Article
Exploring prognostic survival factors in patients with advanced pancreatic cancer receiving PD-1 inhibitors
2024-02-02
Abstract excerpt
Antitumor therapy has now entered the era of immunotherapy represented by programmed cell death protein-1 (PD-1) inhibitors, but predicting the prognosis of immunotherapy for pancreatic cancer (PC) remains challenging. The aim of this study was to evaluate the factors influencing the prognosis of PC patients who had received PD-1 inhibitor therapy. This study was a single-center, retrospective, observational study...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6c027d8a-96f7-57bb-a1ac-cefc2d5388de
- DOI
- 10.21203/rs.3.rs-3893455/v1